Cargando…
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferior...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446840/ https://www.ncbi.nlm.nih.gov/pubmed/35793732 http://dx.doi.org/10.1016/j.amjms.2022.06.021 |
_version_ | 1784783728718905344 |
---|---|
author | Danila, Maria I. Sun, Dongmei Jackson, Lesley E. Cutter, Gary Jackson, Elizabeth A. Ford, Eric W. DeLaney, Erin Mudano, Amy Foster, Phillip J. Rosas, Giovanna Melnick, Joshua A. Curtis, Jeffrey R. Saag, Kenneth G. |
author_facet | Danila, Maria I. Sun, Dongmei Jackson, Lesley E. Cutter, Gary Jackson, Elizabeth A. Ford, Eric W. DeLaney, Erin Mudano, Amy Foster, Phillip J. Rosas, Giovanna Melnick, Joshua A. Curtis, Jeffrey R. Saag, Kenneth G. |
author_sort | Danila, Maria I. |
collection | PubMed |
description | BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferiority trial in multispecialty clinics at a tertiary academic medical center. Adults age ≥ 60 years or with Medicare/Medicaid insurance were eligible. Primary outcome was visit satisfaction rate (9 or 10 on a 0-10 satisfaction scale). Noninferiority was determined if satisfaction with phone-only (intervention) versus video visits (comparator) was no worse by a -15% prespecified noninferiority margin. We performed modified intent-to-treat (mITT) and per protocol analyses, after adjusting for age and insurance. RESULTS: 200 participants, 43% Black, 68% women completed surveys. Visit satisfaction rates were high. In the mITT analysis, phone-only visits were noninferior by an adjusted difference of 3.2% (95% CI, -7.6% to 14%). In the per protocol analysis, phone-only were noninferior by an adjusted difference of -4.1% (95% CI, -14.8% to 6.6%). The proportion of participants who indicated they preferred the same type of telemedicine visit as their next clinic visit were similar (30.2% vs 27.9% video vs phone-only, p = 0.78) and a majority said their medical concerns were addressed and would recommend a telemedicine visit. CONCLUSIONS: Among a group of diverse, established older or underserved patients, the satisfaction rate for phone-only was noninferior to video visits. These findings could impact practice and policies governing telemedicine. |
format | Online Article Text |
id | pubmed-9446840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94468402022-09-06 Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial Danila, Maria I. Sun, Dongmei Jackson, Lesley E. Cutter, Gary Jackson, Elizabeth A. Ford, Eric W. DeLaney, Erin Mudano, Amy Foster, Phillip J. Rosas, Giovanna Melnick, Joshua A. Curtis, Jeffrey R. Saag, Kenneth G. Am J Med Sci Clinical Investigation BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferiority trial in multispecialty clinics at a tertiary academic medical center. Adults age ≥ 60 years or with Medicare/Medicaid insurance were eligible. Primary outcome was visit satisfaction rate (9 or 10 on a 0-10 satisfaction scale). Noninferiority was determined if satisfaction with phone-only (intervention) versus video visits (comparator) was no worse by a -15% prespecified noninferiority margin. We performed modified intent-to-treat (mITT) and per protocol analyses, after adjusting for age and insurance. RESULTS: 200 participants, 43% Black, 68% women completed surveys. Visit satisfaction rates were high. In the mITT analysis, phone-only visits were noninferior by an adjusted difference of 3.2% (95% CI, -7.6% to 14%). In the per protocol analysis, phone-only were noninferior by an adjusted difference of -4.1% (95% CI, -14.8% to 6.6%). The proportion of participants who indicated they preferred the same type of telemedicine visit as their next clinic visit were similar (30.2% vs 27.9% video vs phone-only, p = 0.78) and a majority said their medical concerns were addressed and would recommend a telemedicine visit. CONCLUSIONS: Among a group of diverse, established older or underserved patients, the satisfaction rate for phone-only was noninferior to video visits. These findings could impact practice and policies governing telemedicine. Elsevier 2022-11 2022-07-03 /pmc/articles/PMC9446840/ /pubmed/35793732 http://dx.doi.org/10.1016/j.amjms.2022.06.021 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Investigation Danila, Maria I. Sun, Dongmei Jackson, Lesley E. Cutter, Gary Jackson, Elizabeth A. Ford, Eric W. DeLaney, Erin Mudano, Amy Foster, Phillip J. Rosas, Giovanna Melnick, Joshua A. Curtis, Jeffrey R. Saag, Kenneth G. Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title | Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title_full | Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title_fullStr | Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title_full_unstemmed | Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title_short | Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial |
title_sort | satisfaction with modes of telemedicine delivery during covid-19: a randomized, single-blind, parallel group, noninferiority trial |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446840/ https://www.ncbi.nlm.nih.gov/pubmed/35793732 http://dx.doi.org/10.1016/j.amjms.2022.06.021 |
work_keys_str_mv | AT danilamariai satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT sundongmei satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT jacksonlesleye satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT cuttergary satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT jacksonelizabetha satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT fordericw satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT delaneyerin satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT mudanoamy satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT fosterphillipj satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT rosasgiovanna satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT melnickjoshuaa satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT curtisjeffreyr satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial AT saagkennethg satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial |